 | • レポートコード：MRC2-11QY12371 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、156ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は不妊症サービスのグローバル市場について調査・分析したレポートです。種類別（生殖補助医療（ART）、不妊治療薬サービス、人工授精、不妊治療）市場規模、用途別（男性、女性）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別不妊症サービスの競争状況、市場シェア ・世界の不妊症サービス市場：種類別市場規模 2015年-2020年（生殖補助医療（ART）、不妊治療薬サービス、人工授精、不妊治療） ・世界の不妊症サービス市場：種類別市場規模予測 2021年-2026年（生殖補助医療（ART）、不妊治療薬サービス、人工授精、不妊治療） ・世界の不妊症サービス市場：用途別市場規模 2015年-2020年（男性、女性） ・世界の不妊症サービス市場：用途別市場規模予測 2021年-2026年（男性、女性） ・北米の不妊症サービス市場分析：米国、カナダ ・ヨーロッパの不妊症サービス市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの不妊症サービス市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の不妊症サービス市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの不妊症サービス市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：CARE facility、CooperSurgical、Ferring Pharmaceuticals、Monash IVF、Merck、Vitrolife、AbbVie、Apricus Biosciences、AstraZeneca、Auxogyn、Eli Lilly、EMD Serono、IKS International、InVitro Care、INVO Bioscience、Irvine Scientific、LifeGlobal、MedITEX、NMC Health、OB GYN Associates、OvaScience、Pantec Biosolutions、Reproductive Medicine Associates of New Jersey、The Sims Clinic、TriHealth、Virtus Health、Xytex Cryo International ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat.
Some infertility services include Assisted Reproductive Technology (ART), Infertility drug services, Artificial Insemination and Fertility Surgeries.
Market Analysis and Insights: Global Infertility Services Market
The global Infertility Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Infertility Services Scope and Market Size
Infertility Services market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infertility Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
CARE facility
CooperSurgical
Ferring Pharmaceuticals
Monash IVF
Merck
Vitrolife
AbbVie
Apricus Biosciences
AstraZeneca
Auxogyn
Eli Lilly
EMD Serono
IKS International
InVitro Care
INVO Bioscience
Irvine Scientific
LifeGlobal
MedITEX
NMC Health
OB GYN Associates
OvaScience
Pantec Biosolutions
Reproductive Medicine Associates of New Jersey
The Sims Clinic
TriHealth
Virtus Health
Xytex Cryo International
Market segment by Type, the product can be split into
Assisted Reproductive Technology (ART)
Infertility drug services
Artificial Insemination
Fertility Surgeries
Market segment by Application, split into
Male
Female
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infertility Services Revenue
1.4 Market by Type
1.4.1 Global Infertility Services Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Assisted Reproductive Technology (ART)
1.4.3 Infertility drug services
1.4.4 Artificial Insemination
1.4.5 Fertility Surgeries
1.5 Market by Application
1.5.1 Global Infertility Services Market Share by Application: 2020 VS 2026
1.5.2 Male
1.5.3 Female
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Infertility Services Market Perspective (2015-2026)
2.2 Global Infertility Services Growth Trends by Regions
2.2.1 Infertility Services Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infertility Services Historic Market Share by Regions (2015-2020)
2.2.3 Infertility Services Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Infertility Services Market Growth Strategy
2.3.6 Primary Interviews with Key Infertility Services Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Infertility Services Players by Market Size
3.1.1 Global Top Infertility Services Players by Revenue (2015-2020)
3.1.2 Global Infertility Services Revenue Market Share by Players (2015-2020)
3.1.3 Global Infertility Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infertility Services Market Concentration Ratio
3.2.1 Global Infertility Services Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infertility Services Revenue in 2019
3.3 Infertility Services Key Players Head office and Area Served
3.4 Key Players Infertility Services Product Solution and Service
3.5 Date of Enter into Infertility Services Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Infertility Services Historic Market Size by Type (2015-2020)
4.2 Global Infertility Services Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Infertility Services Market Size by Application (2015-2020)
5.2 Global Infertility Services Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Infertility Services Market Size (2015-2020)
6.2 Infertility Services Key Players in North America (2019-2020)
6.3 North America Infertility Services Market Size by Type (2015-2020)
6.4 North America Infertility Services Market Size by Application (2015-2020)
7 Europe
7.1 Europe Infertility Services Market Size (2015-2020)
7.2 Infertility Services Key Players in Europe (2019-2020)
7.3 Europe Infertility Services Market Size by Type (2015-2020)
7.4 Europe Infertility Services Market Size by Application (2015-2020)
8 China
8.1 China Infertility Services Market Size (2015-2020)
8.2 Infertility Services Key Players in China (2019-2020)
8.3 China Infertility Services Market Size by Type (2015-2020)
8.4 China Infertility Services Market Size by Application (2015-2020)
9 Japan
9.1 Japan Infertility Services Market Size (2015-2020)
9.2 Infertility Services Key Players in Japan (2019-2020)
9.3 Japan Infertility Services Market Size by Type (2015-2020)
9.4 Japan Infertility Services Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Infertility Services Market Size (2015-2020)
10.2 Infertility Services Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infertility Services Market Size by Type (2015-2020)
10.4 Southeast Asia Infertility Services Market Size by Application (2015-2020)
11 India
11.1 India Infertility Services Market Size (2015-2020)
11.2 Infertility Services Key Players in India (2019-2020)
11.3 India Infertility Services Market Size by Type (2015-2020)
11.4 India Infertility Services Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Infertility Services Market Size (2015-2020)
12.2 Infertility Services Key Players in Central & South America (2019-2020)
12.3 Central & South America Infertility Services Market Size by Type (2015-2020)
12.4 Central & South America Infertility Services Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 CARE facility
13.1.1 CARE facility Company Details
13.1.2 CARE facility Business Overview
13.1.3 CARE facility Infertility Services Introduction
13.1.4 CARE facility Revenue in Infertility Services Business (2015-2020))
13.1.5 CARE facility Recent Development
13.2 CooperSurgical
13.2.1 CooperSurgical Company Details
13.2.2 CooperSurgical Business Overview
13.2.3 CooperSurgical Infertility Services Introduction
13.2.4 CooperSurgical Revenue in Infertility Services Business (2015-2020)
13.2.5 CooperSurgical Recent Development
13.3 Ferring Pharmaceuticals
13.3.1 Ferring Pharmaceuticals Company Details
13.3.2 Ferring Pharmaceuticals Business Overview
13.3.3 Ferring Pharmaceuticals Infertility Services Introduction
13.3.4 Ferring Pharmaceuticals Revenue in Infertility Services Business (2015-2020)
13.3.5 Ferring Pharmaceuticals Recent Development
13.4 Monash IVF
13.4.1 Monash IVF Company Details
13.4.2 Monash IVF Business Overview
13.4.3 Monash IVF Infertility Services Introduction
13.4.4 Monash IVF Revenue in Infertility Services Business (2015-2020)
13.4.5 Monash IVF Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Infertility Services Introduction
13.5.4 Merck Revenue in Infertility Services Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Vitrolife
13.6.1 Vitrolife Company Details
13.6.2 Vitrolife Business Overview
13.6.3 Vitrolife Infertility Services Introduction
13.6.4 Vitrolife Revenue in Infertility Services Business (2015-2020)
13.6.5 Vitrolife Recent Development
13.7 AbbVie
13.7.1 AbbVie Company Details
13.7.2 AbbVie Business Overview
13.7.3 AbbVie Infertility Services Introduction
13.7.4 AbbVie Revenue in Infertility Services Business (2015-2020)
13.7.5 AbbVie Recent Development
13.8 Apricus Biosciences
13.8.1 Apricus Biosciences Company Details
13.8.2 Apricus Biosciences Business Overview
13.8.3 Apricus Biosciences Infertility Services Introduction
13.8.4 Apricus Biosciences Revenue in Infertility Services Business (2015-2020)
13.8.5 Apricus Biosciences Recent Development
13.9 AstraZeneca
13.9.1 AstraZeneca Company Details
13.9.2 AstraZeneca Business Overview
13.9.3 AstraZeneca Infertility Services Introduction
13.9.4 AstraZeneca Revenue in Infertility Services Business (2015-2020)
13.9.5 AstraZeneca Recent Development
13.10 Auxogyn
13.10.1 Auxogyn Company Details
13.10.2 Auxogyn Business Overview
13.10.3 Auxogyn Infertility Services Introduction
13.10.4 Auxogyn Revenue in Infertility Services Business (2015-2020)
13.10.5 Auxogyn Recent Development
13.11 Eli Lilly
10.11.1 Eli Lilly Company Details
10.11.2 Eli Lilly Business Overview
10.11.3 Eli Lilly Infertility Services Introduction
10.11.4 Eli Lilly Revenue in Infertility Services Business (2015-2020)
10.11.5 Eli Lilly Recent Development
13.12 EMD Serono
10.12.1 EMD Serono Company Details
10.12.2 EMD Serono Business Overview
10.12.3 EMD Serono Infertility Services Introduction
10.12.4 EMD Serono Revenue in Infertility Services Business (2015-2020)
10.12.5 EMD Serono Recent Development
13.13 IKS International
10.13.1 IKS International Company Details
10.13.2 IKS International Business Overview
10.13.3 IKS International Infertility Services Introduction
10.13.4 IKS International Revenue in Infertility Services Business (2015-2020)
10.13.5 IKS International Recent Development
13.14 InVitro Care
10.14.1 InVitro Care Company Details
10.14.2 InVitro Care Business Overview
10.14.3 InVitro Care Infertility Services Introduction
10.14.4 InVitro Care Revenue in Infertility Services Business (2015-2020)
10.14.5 InVitro Care Recent Development
13.15 INVO Bioscience
10.15.1 INVO Bioscience Company Details
10.15.2 INVO Bioscience Business Overview
10.15.3 INVO Bioscience Infertility Services Introduction
10.15.4 INVO Bioscience Revenue in Infertility Services Business (2015-2020)
10.15.5 INVO Bioscience Recent Development
13.16 Irvine Scientific
10.16.1 Irvine Scientific Company Details
10.16.2 Irvine Scientific Business Overview
10.16.3 Irvine Scientific Infertility Services Introduction
10.16.4 Irvine Scientific Revenue in Infertility Services Business (2015-2020)
10.16.5 Irvine Scientific Recent Development
13.17 LifeGlobal
10.17.1 LifeGlobal Company Details
10.17.2 LifeGlobal Business Overview
10.17.3 LifeGlobal Infertility Services Introduction
10.17.4 LifeGlobal Revenue in Infertility Services Business (2015-2020)
10.17.5 LifeGlobal Recent Development
13.18 MedITEX
10.18.1 MedITEX Company Details
10.18.2 MedITEX Business Overview
10.18.3 MedITEX Infertility Services Introduction
10.18.4 MedITEX Revenue in Infertility Services Business (2015-2020)
10.18.5 MedITEX Recent Development
13.19 NMC Health
10.19.1 NMC Health Company Details
10.19.2 NMC Health Business Overview
10.19.3 NMC Health Infertility Services Introduction
10.19.4 NMC Health Revenue in Infertility Services Business (2015-2020)
10.19.5 NMC Health Recent Development
13.20 OB GYN Associates
10.20.1 OB GYN Associates Company Details
10.20.2 OB GYN Associates Business Overview
10.20.3 OB GYN Associates Infertility Services Introduction
10.20.4 OB GYN Associates Revenue in Infertility Services Business (2015-2020)
10.20.5 OB GYN Associates Recent Development
13.21 OvaScience
10.21.1 OvaScience Company Details
10.21.2 OvaScience Business Overview
10.21.3 OvaScience Infertility Services Introduction
10.21.4 OvaScience Revenue in Infertility Services Business (2015-2020)
10.21.5 OvaScience Recent Development
13.22 Pantec Biosolutions
10.22.1 Pantec Biosolutions Company Details
10.22.2 Pantec Biosolutions Business Overview
10.22.3 Pantec Biosolutions Infertility Services Introduction
10.22.4 Pantec Biosolutions Revenue in Infertility Services Business (2015-2020)
10.22.5 Pantec Biosolutions Recent Development
13.23 Reproductive Medicine Associates of New Jersey
10.23.1 Reproductive Medicine Associates of New Jersey Company Details
10.23.2 Reproductive Medicine Associates of New Jersey Business Overview
10.23.3 Reproductive Medicine Associates of New Jersey Infertility Services Introduction
10.23.4 Reproductive Medicine Associates of New Jersey Revenue in Infertility Services Business (2015-2020)
10.23.5 Reproductive Medicine Associates of New Jersey Recent Development
13.24 The Sims Clinic
10.24.1 The Sims Clinic Company Details
10.24.2 The Sims Clinic Business Overview
10.24.3 The Sims Clinic Infertility Services Introduction
10.24.4 The Sims Clinic Revenue in Infertility Services Business (2015-2020)
10.24.5 The Sims Clinic Recent Development
13.25 TriHealth
10.25.1 TriHealth Company Details
10.25.2 TriHealth Business Overview
10.25.3 TriHealth Infertility Services Introduction
10.25.4 TriHealth Revenue in Infertility Services Business (2015-2020)
10.25.5 TriHealth Recent Development
13.26 Virtus Health
10.26.1 Virtus Health Company Details
10.26.2 Virtus Health Business Overview
10.26.3 Virtus Health Infertility Services Introduction
10.26.4 Virtus Health Revenue in Infertility Services Business (2015-2020)
10.26.5 Virtus Health Recent Development
13.27 Xytex Cryo International
10.27.1 Xytex Cryo International Company Details
10.27.2 Xytex Cryo International Business Overview
10.27.3 Xytex Cryo International Infertility Services Introduction
10.27.4 Xytex Cryo International Revenue in Infertility Services Business (2015-2020)
10.27.5 Xytex Cryo International Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Infertility Services Key Market Segments
Table 2. Key Players Covered: Ranking by Infertility Services Revenue
Table 3. Ranking of Global Top Infertility Services Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infertility Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Assisted Reproductive Technology (ART)
Table 6. Key Players of Infertility drug services
Table 7. Key Players of Artificial Insemination
Table 8. Key Players of Fertility Surgeries
Table 9. Global Infertility Services Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Infertility Services Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Infertility Services Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Infertility Services Market Share by Regions (2015-2020)
Table 13. Global Infertility Services Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Infertility Services Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Infertility Services Market Growth Strategy
Table 19. Main Points Interviewed from Key Infertility Services Players
Table 20. Global Infertility Services Revenue by Players (2015-2020) (Million US$)
Table 21. Global Infertility Services Market Share by Players (2015-2020)
Table 22. Global Top Infertility Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infertility Services as of 2019)
Table 23. Global Infertility Services by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Infertility Services Product Solution and Service
Table 26. Date of Enter into Infertility Services Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infertility Services Market Size by Type (2015-2020) (Million US$)
Table 29. Global Infertility Services Market Size Share by Type (2015-2020)
Table 30. Global Infertility Services Revenue Market Share by Type (2021-2026)
Table 31. Global Infertility Services Market Size Share by Application (2015-2020)
Table 32. Global Infertility Services Market Size by Application (2015-2020) (Million US$)
Table 33. Global Infertility Services Market Size Share by Application (2021-2026)
Table 34. North America Key Players Infertility Services Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Infertility Services Market Share (2019-2020)
Table 36. North America Infertility Services Market Size by Type (2015-2020) (Million US$)
Table 37. North America Infertility Services Market Share by Type (2015-2020)
Table 38. North America Infertility Services Market Size by Application (2015-2020) (Million US$)
Table 39. North America Infertility Services Market Share by Application (2015-2020)
Table 40. Europe Key Players Infertility Services Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Infertility Services Market Share (2019-2020)
Table 42. Europe Infertility Services Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Infertility Services Market Share by Type (2015-2020)
Table 44. Europe Infertility Services Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Infertility Services Market Share by Application (2015-2020)
Table 46. China Key Players Infertility Services Revenue (2019-2020) (Million US$)
Table 47. China Key Players Infertility Services Market Share (2019-2020)
Table 48. China Infertility Services Market Size by Type (2015-2020) (Million US$)
Table 49. China Infertility Services Market Share by Type (2015-2020)
Table 50. China Infertility Services Market Size by Application (2015-2020) (Million US$)
Table 51. China Infertility Services Market Share by Application (2015-2020)
Table 52. Japan Key Players Infertility Services Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Infertility Services Market Share (2019-2020)
Table 54. Japan Infertility Services Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Infertility Services Market Share by Type (2015-2020)
Table 56. Japan Infertility Services Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Infertility Services Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Infertility Services Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Infertility Services Market Share (2019-2020)
Table 60. Southeast Asia Infertility Services Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Infertility Services Market Share by Type (2015-2020)
Table 62. Southeast Asia Infertility Services Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Infertility Services Market Share by Application (2015-2020)
Table 64. India Key Players Infertility Services Revenue (2019-2020) (Million US$)
Table 65. India Key Players Infertility Services Market Share (2019-2020)
Table 66. India Infertility Services Market Size by Type (2015-2020) (Million US$)
Table 67. India Infertility Services Market Share by Type (2015-2020)
Table 68. India Infertility Services Market Size by Application (2015-2020) (Million US$)
Table 69. India Infertility Services Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Infertility Services Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Infertility Services Market Share (2019-2020)
Table 72. Central & South America Infertility Services Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Infertility Services Market Share by Type (2015-2020)
Table 74. Central & South America Infertility Services Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Infertility Services Market Share by Application (2015-2020)
Table 76. CARE facility Company Details
Table 77. CARE facility Business Overview
Table 78. CARE facility Product
Table 79. CARE facility Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 80. CARE facility Recent Development
Table 81. CooperSurgical Company Details
Table 82. CooperSurgical Business Overview
Table 83. CooperSurgical Product
Table 84. CooperSurgical Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 85. CooperSurgical Recent Development
Table 86. Ferring Pharmaceuticals Company Details
Table 87. Ferring Pharmaceuticals Business Overview
Table 88. Ferring Pharmaceuticals Product
Table 89. Ferring Pharmaceuticals Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 90. Ferring Pharmaceuticals Recent Development
Table 91. Monash IVF Company Details
Table 92. Monash IVF Business Overview
Table 93. Monash IVF Product
Table 94. Monash IVF Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 95. Monash IVF Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Product
Table 99. Merck Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 100. Merck Recent Development
Table 101. Vitrolife Company Details
Table 102. Vitrolife Business Overview
Table 103. Vitrolife Product
Table 104. Vitrolife Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 105. Vitrolife Recent Development
Table 106. AbbVie Company Details
Table 107. AbbVie Business Overview
Table 108. AbbVie Product
Table 109. AbbVie Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 110. AbbVie Recent Development
Table 111. Apricus Biosciences Business Overview
Table 112. Apricus Biosciences Product
Table 113. Apricus Biosciences Company Details
Table 114. Apricus Biosciences Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 115. Apricus Biosciences Recent Development
Table 116. AstraZeneca Company Details
Table 117. AstraZeneca Business Overview
Table 118. AstraZeneca Product
Table 119. AstraZeneca Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 120. AstraZeneca Recent Development
Table 121. Auxogyn Company Details
Table 122. Auxogyn Business Overview
Table 123. Auxogyn Product
Table 124. Auxogyn Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 125. Auxogyn Recent Development
Table 126. Eli Lilly Company Details
Table 127. Eli Lilly Business Overview
Table 128. Eli Lilly Product
Table 129. Eli Lilly Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 130. Eli Lilly Recent Development
Table 131. EMD Serono Company Details
Table 132. EMD Serono Business Overview
Table 133. EMD Serono Product
Table 134. EMD Serono Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 135. EMD Serono Recent Development
Table 136. IKS International Company Details
Table 137. IKS International Business Overview
Table 138. IKS International Product
Table 139. IKS International Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 140. IKS International Recent Development
Table 141. InVitro Care Company Details
Table 142. InVitro Care Business Overview
Table 143. InVitro Care Product
Table 144. InVitro Care Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 145. InVitro Care Recent Development
Table 146. INVO Bioscience Company Details
Table 147. INVO Bioscience Business Overview
Table 148. INVO Bioscience Product
Table 149. INVO Bioscience Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 150. INVO Bioscience Recent Development
Table 151. Irvine Scientific Company Details
Table 152. Irvine Scientific Business Overview
Table 153. Irvine Scientific Product
Table 154. Irvine Scientific Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 155. Irvine Scientific Recent Development
Table 156. LifeGlobal Company Details
Table 157. LifeGlobal Business Overview
Table 158. LifeGlobal Product
Table 159. LifeGlobal Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 160. LifeGlobal Recent Development
Table 161. MedITEX Company Details
Table 162. MedITEX Business Overview
Table 163. MedITEX Product
Table 164. MedITEX Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 165. MedITEX Recent Development
Table 166. NMC Health Company Details
Table 167. NMC Health Business Overview
Table 168. NMC Health Product
Table 169. NMC Health Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 170. NMC Health Recent Development
Table 171. OB GYN Associates Company Details
Table 172. OB GYN Associates Business Overview
Table 173. OB GYN Associates Product
Table 174. OB GYN Associates Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 175. OB GYN Associates Recent Development
Table 176. OvaScience Company Details
Table 177. OvaScience Business Overview
Table 178. OvaScience Product
Table 179. OvaScience Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 180. OvaScience Recent Development
Table 181. Pantec Biosolutions Company Details
Table 182. Pantec Biosolutions Business Overview
Table 183. Pantec Biosolutions Product
Table 184. Pantec Biosolutions Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 185. Pantec Biosolutions Recent Development
Table 186. Reproductive Medicine Associates of New Jersey Company Details
Table 187. Reproductive Medicine Associates of New Jersey Business Overview
Table 188. Reproductive Medicine Associates of New Jersey Product
Table 189. Reproductive Medicine Associates of New Jersey Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 190. Reproductive Medicine Associates of New Jersey Recent Development
Table 191. The Sims Clinic Company Details
Table 192. The Sims Clinic Business Overview
Table 193. The Sims Clinic Product
Table 194. The Sims Clinic Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 195. The Sims Clinic Recent Development
Table 196. TriHealth Company Details
Table 197. TriHealth Business Overview
Table 198. TriHealth Product
Table 199. TriHealth Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 200. TriHealth Recent Development
Table 201. Virtus Health Company Details
Table 202. Virtus Health Business Overview
Table 203. Virtus Health Product
Table 204. Virtus Health Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 205. Virtus Health Recent Development
Table 206. Xytex Cryo International Company Details
Table 207. Xytex Cryo International Business Overview
Table 208. Xytex Cryo International Product
Table 209. Xytex Cryo International Revenue in Infertility Services Business (2015-2020) (Million US$)
Table 210. Xytex Cryo International Recent Development
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infertility Services Market Share by Type: 2020 VS 2026
Figure 2. Assisted Reproductive Technology (ART) Features
Figure 3. Infertility drug services Features
Figure 4. Artificial Insemination Features
Figure 5. Fertility Surgeries Features
Figure 6. Global Infertility Services Market Share by Application: 2020 VS 2026
Figure 7. Male Case Studies
Figure 8. Female Case Studies
Figure 9. Infertility Services Report Years Considered
Figure 10. Global Infertility Services Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Infertility Services Market Share by Regions: 2020 VS 2026
Figure 12. Global Infertility Services Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Infertility Services Market Share by Players in 2019
Figure 15. Global Top Infertility Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infertility Services as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Infertility Services Revenue in 2019
Figure 17. North America Infertility Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Infertility Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Infertility Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Infertility Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Infertility Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Infertility Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Infertility Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
男性不妊症の世界市場（～2026年） Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing …- 不妊症の世界市場（～2026年） In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat. Estimates from 1997 suggest that worldwide about five percent of all heterosexual couples have an unresolved problem…
- 女性用不妊症診断・治療の世界市場（～2026年） Female infertility refers to infertility in female humans. The major factors that are augmenting the growth of the female infertility market are changing life style and increasing IVF market. Furthermore, rising trend of surrogacy, growing infertility rate among female, new technologies to avoid mul…
- 男性不妊症診断・治療の世界市場（～2026年） Male infertility refers to a male's inability to cause pregnancy in a fertile female. The major factors that are augmenting the growth of the market are estimated to be increasing alcohol consumption, increasing age, rising environmental pollution etc. Additionally, increasing stress, changing life …
- 不妊症診断の世界市場（～2026年） Fertility diagnosis is done by both men and women for the evaluation of their fertility and various conditions associated with it. The assessment of infertility proceeds along simple and logical lines which includes test for eggs, test for sperm, and how they can get together. Additional tests are p…